Humer Kristian 4
4 · Foghorn Therapeutics Inc. · Filed Apr 17, 2024
Insider Transaction Report
Form 4
Humer Kristian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to buy)
2024-04-16$6.03/sh+275,000$1,658,250→ 275,000 totalExercise: $6.03Exp: 2034-04-15→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on April 16, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.